Pharmacogenomic Testing and Warfarin Management.


Warfarin has been used for the prevention of thrombosis for more than 50 years and is the most frequently prescribed vitamin K antagonist in North America (Gage & Eby, 2003). Its mode of action is to prevent vitamin K from converting to vitamin KH2, thereby inhibiting clotting factors (Johnson & Cavallari, 2015). Warfarin metabolism is affected by… (More)
DOI: 10.1188/15.ONF.563-565


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics